您的位置: 专家智库 > >

国家自然科学基金(81100649)

作品数:14 被引量:99H指数:6
相关作者:彭娟沙翔垠杨瑞明郑瑜邵毅更多>>
相关机构:广州医学院第二附属医院广州医科大学南昌大学第一附属医院更多>>
发文基金:国家自然科学基金江西省卫生厅科技计划项目江西省科技支撑计划项目更多>>
相关领域:医药卫生更多>>

文献类型

  • 14篇中文期刊文章

领域

  • 14篇医药卫生

主题

  • 4篇视网膜
  • 4篇网膜
  • 3篇翼状胬肉
  • 3篇增生
  • 3篇视网膜病
  • 3篇视网膜病变
  • 3篇胬肉
  • 3篇细胞
  • 3篇黄斑
  • 3篇病变
  • 3篇玻璃体
  • 2篇信号
  • 2篇增生型
  • 2篇增生型糖尿病...
  • 2篇糖尿
  • 2篇糖尿病
  • 2篇糖尿病视网膜
  • 2篇糖尿病视网膜...
  • 2篇糖尿病视网膜...
  • 2篇曲安奈德

机构

  • 7篇广州医学院第...
  • 3篇广州医科大学
  • 2篇南昌大学第一...
  • 1篇江西省中医院
  • 1篇湖南中医药大...
  • 1篇南方医科大学
  • 1篇南华大学

作者

  • 10篇彭娟
  • 8篇沙翔垠
  • 4篇杨瑞明
  • 3篇郑瑜
  • 2篇吴兴萍
  • 2篇郭露萍
  • 2篇裴重刚
  • 2篇周琼
  • 2篇邵毅
  • 2篇毛雁
  • 1篇杨璐
  • 1篇梅开勇
  • 1篇余瑶
  • 1篇廖君
  • 1篇梅峰
  • 1篇吴晓蓉
  • 1篇占敏艳
  • 1篇谭钢
  • 1篇易昀敏
  • 1篇殷坚

传媒

  • 3篇Intern...
  • 2篇眼科新进展
  • 2篇实用医学杂志
  • 2篇中国实用眼科...
  • 2篇中华实验眼科...
  • 1篇国际眼科杂志
  • 1篇中国医学工程
  • 1篇湖南中医药大...

年份

  • 1篇2020
  • 1篇2019
  • 2篇2015
  • 1篇2014
  • 1篇2013
  • 7篇2012
  • 1篇2011
14 条 记 录,以下是 1-10
排序方式:
Aerocyst urethral catheter insertion compared to expansion sponges application in external dacryocystorhinostomy
2011年
AIM:To evaluate the clinical effect and complications of two different filling materials(aerocyst urethral catheter and expansion sponges) applying in external dacryocystorhin-ostomy(EXT-DCR) and compare their advantages and disadvantages.METHODS:A retrospective study was made in the period from April,1 2000 to April,1 2005.Totally 180 patients(240 eyes) underwent the EX-DCR using different filling materials and divided into three groups randomly:negative control groups(group 1),expansion sponges group(group 2) and aerocyst urethral catheter group(group 3).The gender,etiology,clinical findings,surgical technique,filling materials,the condition of ocular surface and complications were analyzed.Filling materials were removed during day 7.Postoperative success was determined by lacrimal patency to irrigation,a positive dye test,hemorrhage and errhysis conditions after extubation and subjective resolution of epiphora and liquor puris.RESULTS:During a mean follow-up of 5.14±1.69 years,the success rate were 73.7%(group 1),86.5%(group 2),98.7%(group 3) in three groups.There was significant statistical difference among three groups in the surgical success rate and the operative complications(including hemorrhage,errhysis,periorbital ecchymosis after extubation)(P<0.05).CONCLUSION:EXT-DCR with aerocyst urethral cathete intraoperatively have higher success rate,fewer operative complications and a high patient satisfaction,and can be used to simplify and speed up traditional EXT-DCR.
Yi Shao,Gui-Ping Gao
关键词:URETHRALCATHETERFILLINGDACRYOCYSTORHINOSTOMY
鬼针草叶治疗非增生型糖尿病视网膜病变的临床研究被引量:11
2013年
目的观察鬼针草叶治疗非增生型糖尿病视网膜病变的临床疗效。方法前瞻性随机对照研究。32例(64眼)非增生型糖尿病视网膜病变患者随机分为A、B两组,在严格控制血糖及血压基础上,A组口服鬼针草叶(15.0g),B组口服安慰剂维生素C片0.1g,均每日3次,饭前0.5h口服,两组均常规口服羟苯磺酸钙分散片0.5g,每日3次,连续服用21d。观察患者治疗前后视力、眼底荧光血管造影、眼底照相及中医症候的变化。结果治疗21d后,视力提高38眼,其中A组24眼(75.0%),B组14眼(43.8%),两组比较差异有统计学意义(P<0.05);32眼治疗后最佳矫正视力>0.05,其中A组22眼(68.8%),B组10眼(31.2%),两组比较差异有统计学意义(P<0.05)。A组眼底病变治疗有效率为31.3%,总有效率81.3%;B组有效率21.9%,总有效率65.6%,两组有效率比较差异有统计学意义(P<0.05)。A组中医症候显效率31.3%,总有效率81.3%;B组显效率18.8%,总有效率62.5%,两组总有效率比较差异有统计学意义(P<0.05)。结论鬼针草叶可提高非增生型糖尿病视网膜病变患者视力,有效改善其眼底病变及减轻中医症候。
邵毅周琼易昀敏余瑶裴重刚吴晓蓉梅峰占敏艳
关键词:视力中医症候
Pterygium epithelium abnormal differentiation related to activation of extracellular signal-regulated kinase signaling pathway in vitro被引量:5
2015年
AIM: To investigate whether the abnormal differentiation of the pterygium epithelium is related to the extracellular signal-regulated kinase(ERK) signaling pathway in vitro.·METHODS: The expression levels of phosphorylated ERK(P-ERK), keratin family members including K19 and K10 and the ocular master control gene Pax-6 were measured in 16 surgically excised pterygium tissues and 12 eye bank conjunctiva. In colony-forming cell assays,the differences in clone morphology and in K10, K19, PERK and Pax-6 expression between the head and body were investigated. When cocultured with the ERK signaling pathway inhibitor PD98059, the changes in clone morphology, colony-forming efficiency,differentiated marker K10, K19 and Pax-6 expression and P-ERK protein expression level were examined by immunoreactivity and Western blot analysis.· RESULTS: The expression of K19 and Pax-6 decreased in the pterygium, especially in the head. No staining of K10 was found in the normal conjunctiva epithelium, but it was found to be expressed in the superficial cells in the head of the pterygium.Characteristic upregulation of P-ERK was observed by immunohistochemistry. The clone from the head with more differentiated cells in the center expressed more K10, and the clone from the body expressed more K19.The P-ERK protein level increased in the pterygium epithelium compared with conjunctiva and decreased when cocultured with PD98059. The same medium with the ERK inhibitor PD98059 was more effective in promoting clonal growth than conventional medium with3T3 murine feeder layers. It was observed that the epithelium clone co-cultured with the inhibitor had decreased K10 expression and increased K19 and Pax-6 expression.· CONCLUSION: We suggest ERK signaling pathway activation might play a role in the pterygium epithelium abnormal differentiation.
Juan PengXiang-Yin ShaYi LiuRui-Ming YangYe Wen
关键词:PTERYGIUM
异黄酮片治疗更年期女性中重度干眼症临床研究被引量:13
2012年
目的探讨异黄酮片对更年期女性中重度干眼的治疗效果。方法采用前瞻性随机双盲对照研究方法。将2010年8月至2011年3月在两所医院眼科门诊确诊为中重度干眼症的76例女性患者(76只眼)随机分为两组:口服异黄酮片组38例,口服维生素C安慰剂对照组38例。两组均加用0.05%羧甲基纤维素钠眼液滴眼治疗;分别在治疗前和治疗后3、7、28d各时间点检测并评定患者干眼主观症状、视力、角膜荧光素染色(n)、泪膜破裂时间(BUT)及基础泪液分泌试验(SIT),治疗前后及两组间均进行方差分析和样本均数或中位数差值分析。结果治疗28d后,异黄酮片组中重度干眼的样本均数差值[1.24(视疲劳)、1.32(干涩感)、0.88(异物感)、1.42(烧灼感)、1.28(畏光)、1.64(疼痛)、1.56(眼红)],以及样本中位数差值[0.30(视力)、5.00(FI染色)、5.00(BUT)、5.00(SIT)],均较治疗前明显改善[22.60(视疲劳),23.40(干涩感),19.20(异物感),28.90(烧灼感),18.50(畏光),36.80(疼痛),15.20(眼红)、11.50(视力),209.85(F1染色),276.80(BUT),325.42(SIT);均为P〈0.05差异有统计学意义]。在全部28d观察期间内,安慰剂组中重度干眼的样本均数差值[0.16(视疲劳)、0.22(干涩感)、0.13(异物感)、0.42(烧灼感)、0.28(眼红)],以及样本中位数差值[0.20(视力)、0.50(F1染色)、0.50(BUT)、0.50(SIT)],均较治疗前无明显改善[2.12(视疲劳),1.98(于涩感),1.64(异物感),3.32(烧灼感),3.47(眼红)、1.36(视力),4.08(F1染色),3.16(BUT)。3.88(sIT);差异无统计学意义P值均〉0.05]。异黄酮片组SIT值较安慰剂组改善差异有统计学意义(F=6.22,P〈0.05),SIT值达正常�
邵毅裴重刚周琼余瑶谭钢董雯佳彭娟杨璐
关键词:干眼女性
玻璃体腔内注射曲安奈德治疗渗出型老年性黄斑变性临床观察被引量:12
2012年
目的:观察玻璃体腔内注射曲安奈德治疗渗出型老年性黄斑变性的疗效和安全性。方法:收集2011年1月至2012年1月渗出型老年性黄斑变性患者11例11眼为治疗组,收集同期7例患者为对照组。治疗组患者均接受玻璃体腔内注射曲安奈德4mg。对照组采用保守治疗。观察术前术后视力及眼压情况,荧光造影及光学相干视网膜断层成像检测黄斑情况。结果:治疗组术后患者视力均有提高,术后3个月视力提高明显平均值0.32±0.12。术后视力提高值与术前视力呈负相关。术后眼压值升高,术后1个月眼压值为(20.15±9.45)mmHg,术后3个月眼压值降至正常范围,平均眼压值(18.57±8.76)mmHg。术后3个月黄斑中心凹厚度变薄为(219.12±12.81)μm。与对照组比较,治疗组术后3个月视力有明显提高,黄斑中心凹厚度明显变薄。结论:玻璃体腔内注射曲安奈德能有效提高渗出型老年性黄斑变性患者的视力,有一过性眼压升高是安全,有效的治疗方法之一。
彭娟沙翔垠杨瑞明郑瑜吴兴萍郭露萍
关键词:黄斑变性玻璃体腔注射曲安奈德
Evaluation of novel decellularizing corneal stroma for cornea tissue engineering applications被引量:16
2012年
·AIM:To develop a new decellularization method depended upon the natural corneal structure and to harvest an ideal scaffold with good biocompatibilities for corneal reconstruction.METHODS:The acellular cornea matrix (ACM) were prepared from de-epithelium fresh porcine corneas (DFPCs) by incubation with 100% fresh human sera and additional electrophoresis at 4℃. Human corneal epithelial cells (HCEs) were used for the cytotoxicity tests of ACM. ACM were implanted into the Enhanced Green Fluorecence Protein (eGFP) transgenic mouse anterior chamber for evaluation of histocompatibility.RESULTS:HE and GSIB4 results showed fresh porcine cornea matrix with 100% human sera and electrophoresis could entirely decellularize stromal cell without reducing its transparency. ACM has no cytotoxic effect ex vivo. Animal test showed there was no rejection for one month after surgery.CONCLUSION:These results provide a decellularizing approach for the study of corneal tissue engineering and had the broader implications for the field of biological tissue engineering in other engineered organ or tissue matrix.
Yi Shao,Lu Yang
关键词:CORNEASERAELECTROPHORESISDECELLULARIZATIONBIOCOMPATIBILITY
单侧与双侧翼状胬肉成纤维细胞生物学行为的差异及紫外线对其的影响被引量:5
2020年
目的探讨单侧与双侧人翼状胬肉成纤维细胞(HPFs)增生和移行的差异及紫外线对不同部位成纤维细胞增生和移行的影响。方法收集2017年3月至2018年3月于广州医科大学附属第二医院行翼状胬肉切除+自体结膜瓣转位术的双侧及单侧翼状胬肉患者各19例19眼的翼状胬肉组织。6例12眼正常结膜组织来源于同期供体眼球。根据病种和培养取材部位分为鼻侧HPFs(HPFs-N)19例、颞侧HPFs(HPFs-T)19例、单侧HPFs 19例和人正常结膜成纤维细胞(HCFs)12例,分别取自双侧翼状胬肉的鼻侧、双侧翼状胬肉的颞侧、单侧翼状胬肉和正常结膜。将以上成纤维细胞分为紫外线照射组和普通光照组,分别接受紫外线B(UVB)和普通光照照射。采用MTT法检测细胞生长曲线,细胞划痕试验检测48 h细胞划痕愈合率,免疫荧光法检测α平滑肌肌动蛋白(α-SMA)的表达。比较各成纤维细胞增生和移行能力的差异。比较紫外线照射组和普通光照组细胞划痕愈合率、生长曲线及α-SMA表达的改变。结果组织块培养法可见HCFs及HPFs呈梭形生长。各成纤维细胞体外培养1~7 d生长速度逐渐加快,HPFs-N生长最快,HCFs生长速度最慢。在紫外线照射下各成纤维细胞生长速度较普通光照组明显加快。4种成纤维细胞不同光照条件下细胞划痕愈合率、α-SMA阳性细胞表达率比较差异均有统计学意义(F组别=158.064,P<0.05;F细胞类型=326.582,P<0.05.F组别=4.731,P<0.05;F细胞类型=172.813,P<0.05),其中普通光照条件下,48 h后HPFs-N的细胞划痕愈合率为(79.67±0.86)%,明显高于HPFs-T、单侧HPFs和HCFs的(54.04±0.33)%、(64.12±0.21)%和(58.86±0.41)%,HPFs-N的α-SMA阳性细胞表达率为(28.87±1.02)%,明显高于HPFs-T、单侧HPFs和HCFs的(13.67±0.23)%、(20.35±1.72)%和(5.12±0.45)%,差异均有统计学意义(均P<0.05);与普通光照组比较,紫外线照射组各成纤维细胞的细胞划痕愈合率、α-SMA阳性细胞表达率明�
彭娟毛雁姚达强董舒婷沙翔垠
关键词:翼状胬肉成纤维细胞增生
翼状胬肉与睑裂斑组织病理结构及磷酸化细胞外信号调节激酶、含IQ模序的GTP酶活化蛋白1表达的对比研究被引量:3
2019年
目的探讨翼状胬肉与睑裂斑的病理改变差异和磷酸化细胞外信号调节激酶(p-ERK)及含IQ模序的GTP酶活化蛋白1(IQGAP1)的表达,比较其在翼状胬肉、睑裂斑中的差异。方法 8例翼状胬肉、睑裂斑病理及正常结膜组织,HE染色显示组织结构,免疫组化检测各组织中p-ERK和IQGAP1的表达。结果上皮层数比较:翼状胬肉>睑裂斑>结膜。血管数量比较:翼状胬肉>睑裂斑>结膜。翼状胬肉、睑裂斑组织中p-ERK、IQGAP1表达水平明显高于正常结膜。相关分析显示翼状胬肉中p-ERK与IQGAP1表达呈正相关。结论翼状胬肉和睑裂斑中的p-ERK和IQGAP1表达增加,共同参与翼状胬肉、睑裂斑的发病过程。翼状胬肉和睑裂斑的发病机制可能有一定相似性。
董舒婷彭娟沙翔垠姚达强戴棐曌毛雁
关键词:翼状胬肉P-ERKIQGAP1
翼状胬肉上皮细胞表达的研究中β-catenin和Cyclin D1表达的研究被引量:4
2012年
目的探讨翼状胬肉上皮细胞的病理改变和β-catenin/Wnt信号通路及其下游靶基因cyclinD1的表达。并比较其与复发性翼状胬肉的表达差异。方法收集翼状胬肉组织26例,其中复发翼状胬肉8例。正常结膜组织6例。冰冻包埋后行HE和免疫组织化学和免疫荧光染色,检测上皮细胞中β-catenin和CyclinD1的表达。并作相关分析。结果翼状胬肉上皮细胞增生,上皮细胞中β-catenin和CyclinD1表达水平明显高于正常结膜。β-catenin表达平均阳性细胞数124.85±9.25,积分光密度826.56±10.25。CyclinD1表达平均阳性细胞数90.40±9.63,积分光密度531.85±12.36。β-catenin和Cv—clinD1表达水平具有正相关。在复发性翼状胬肉上皮细胞中β-catenin和CyclinD1表达水平较初发翼状胬肉有增加。其中β-catenin表达平均阳性细胞数295.12±11.26,积分光密度1145.25±16.58。Cyclin D1表达平均阳性细胞数162.54±9.24,积分光密度856.26±13.85,差异有统计学意义。结论Wnt/β-catenin通路可能通过CvclinD1参与翼状胬肉上皮细胞的发病过程。
彭娟沙翔垠
关键词:翼状胬肉上皮细胞Β-CATENINCYCLIND1
玻璃体切割联合曲安奈德注射治疗增生型糖尿病视网膜病变被引量:7
2012年
目的观察玻璃体切割联合曲安奈德玻璃体腔内注射治疗增生型糖尿病视网膜病变的临床疗效及并发症。方法收集2011年2月至2012年1月增生型糖尿病视网膜病变患者60例69眼,患者均接受玻璃体切割手术,术中注射曲安奈德。观察术后视力及眼压情况,光学相干视网膜断层成像检测黄斑中心凹厚度变化及术后并发症。结果术后患者视力均有提高,术后3月稳定。最佳矫正视力为0.56±0.18.术后黄斑水肿减退,黄斑中心凹厚度减低,3月后基本恢复正常253±169μm。眼压术后有增加,术后7d为19.42±6.97mmHg,术后1月为24.14±11.25mmHg,用药后基本可以降至正常,术后3月19.21±6.45mmHg。结论玻璃体切割联合曲安奈德玻璃体腔内注射能减轻黄斑水肿,逐步改善视功能,是治疗增生型糖尿病视网膜病变的有效,安全手段。
彭娟沙翔垠杨瑞明郑瑜吴兴萍郭露萍
关键词:玻璃体切割糖尿病视网膜病变曲安奈德
共2页<12>
聚类工具0